Banner  

Sitemap | About Us | Contact

 
Home Agriculture Meats Wine Restaurants Medical Chemicals Logistics
Carbon monoxide (CO)
Events
 
Carbon monoxide, with the chemical formula CO, is a colorless, odorless, and tasteless gas. It is the product of the partial combustion of carbon-containing compounds, notably in internal-combustion engines. Carbon monoxide forms in preference to the more usual carbon dioxide when there is a reduced availability of oxygen present during the combustion process. Carbon monoxide has significant fuel value, burning in air with a characteristic blue flame, producing carbon dioxide. Despite its serious toxicity, CO plays a highly useful role in modern technology, being a precursor to myriad products. It consists of one carbon atom covalently bonded to one oxygen atom. It is a gas at room temperature.

Carbon monoxide is used in modified atmosphere packaging systems in the US, mainly with fresh meat products such as beef and pork. The CO combines with myoglobin to form carboxymyoglobin, a bright cherry red pigment.

Carboxymyoglobin is more stable than the oxygenated form of myoglobin, oxymyoglobin, which can become oxidized to the brown pigment, metmyoglobin. This stable red colour can persist much longer than in normally packaged meat, giving the appearance of freshness.  Typical levels of CO used are 0.4% to 0.5%.

The technology was first given generally recognized as safe status by the FDA in 2002 for use as a secondary packaging system. In 2004 the FDA approved CO as primary packaging method, declaring that CO does not mask spoilage odour.  Despite this ruling, the technology remains controversial in the US for fears that it is deceptive and masks spoilage.
One reaction in the body produces CO. Carbon monoxide is produced naturally as a breakdown of heme (which is one of hemoglobin moieties), a substrate for the enzyme heme oxygenase. The enzymatic reaction results in breakdown of heme to CO, biliverdin and Fe3+ radical. The endogenously produced CO may have important physiological roles in the body (eg as a neurotransmitter or a blood vessels relaxant). In addition CO regulates inflammatory reactions in a manner that prevents the development of several diseases such atherosclerosis or severe malaria.

CO is a nutrient for methanogenic bacteria, a building block for acetyl coenzyme A. This theme is the subject for the emerging field of bioorganometallic chemistry. In bacteria, CO is produced via the reduction of carbon dioxide via the enzyme carbon monoxide dehydrogenase, an Fe-Ni-S-containing protein.
A haeme-based CO-sensor protein, CooA, is known.  The scope of its biological role is still unclear, it is apparently part of a signaling pathway in bacteria and archaea, but its occurrence in mammals is not established.

CO is also currently being studied in several research laboratories throughout the world for its anti-inflammatory and cytoprotective properties that can be used therapeutically to prevent the development of a series of pathologic conditions such as ischemia reperfusion injury, transplant rejection, atherosclerosis, sepsis, severe malaria or autoimmunity. There are yet no clinical applications of CO in humans.
  Related Links
News & Press Releases
Business Development
Top Applications
Investor Relations
Contact Us
 
 
EAPIMS | 695 John Muir Dr. Suite #508 | San Francisco, CA 94132 | Tel: 415.509.3515 | Fax: 415.584.2615 | Sitemap | About Us | Contact
Copyright © 2008 EAPIMS. All rights reserved. Terms of Use | Privacy Policy